NASDAQ: XFORX4 Pharmaceuticals Inc Stock Ownership - Who owns X4 Pharmaceuticals?
Insider buying vs selling
Have X4 Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Christophe Arbetengels | Chief Medical Officer | 2025-01-24 | 11,624 | $0.46 | $5.29kSell |
| Mark Baldry | Chief Commercial Officer | 2025-01-24 | 29,159 | $0.45 | $13.24kSell |
| Mary Dibiase | Chief Operating Officer | 2025-01-24 | 22,258 | $0.45 | $10.11kSell |
| Adam S. Mostafa | Chief Financial Officer | 2025-01-24 | 74,773 | $0.45 | $33.95kSell |
| Paula Ragan | President and CEO | 2025-01-24 | 76,473 | $0.45 | $34.72kSell |
| Mark Baldry | Chief Commercial Officer | 2024-11-15 | 13,404 | $0.34 | $4.60kBuy |
| Paula Ragan | President and CEO | 2024-11-15 | 31,897 | $0.40 | $12.60kSell |
| Paula Ragan | President and CEO | 2024-10-15 | 31,897 | $0.56 | $17.93kSell |
| Arthur Taveras | Chief Scientific Officer | 2024-10-07 | 76,920 | $0.56 | $43.31kSell |
| Mark Baldry | Chief Commercial Officer | 2024-10-07 | 11,127 | $0.59 | $6.51kSell |
XFOR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when XFOR insiders and whales buy or sell their stock.
XFOR Shareholders
What type of owners hold X4 Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Bain Capital Life Sciences Investors LLC | 9.74% | 16,915,784 | $3.23M | Institution |
| Nea Management Company LLC | 8.63% | 14,986,793 | $2.86M | Institution |
| Blackrock Inc | 6.37% | 11,060,645 | $2.11M | Institution |
| Vanguard Group Inc | 4.72% | 8,200,903 | $1.57M | Institution |
| Acorn Capital Advisors LLC | 4.21% | 7,310,650 | $1.40M | Institution |
| Orbimed Advisors LLC | 4.11% | 7,133,515 | $1.36M | Institution |
| Kingdon Capital Management LLC | 2.84% | 4,937,000 | $942.97k | Institution |
| Geode Capital Management LLC | 2.01% | 3,497,212 | $667.97k | Institution |
| Paula Ragan | 1.92% | 3,337,386 | $637.44k | Insider |
| Axa Sa | 1.77% | 3,072,143 | $586.78k | Institution |
XFOR vs Biotech Stocks
X4 Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.